Related references
Note: Only part of the references are listed.Long-Term Follow-Up of Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated in the HD7 to HD15 Trials: A Report From the German Hodgkin Study Group
Dennis A. Eichenauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group
Dennis A. Eichenauer et al.
LEUKEMIA (2020)
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma
Sven Borchmann et al.
BLOOD (2019)
Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study
Stefano Luminari et al.
BLOOD (2019)
Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma
Ciara L. Freeman et al.
BLOOD (2019)
Modern principles in the management of nodular lymphocyte-predominant Hodgkin lymphoma
Michael A. Spinner et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma
Chelsea C. Pinnix et al.
BLOOD ADVANCES (2019)
Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D. A. Eichenauer et al.
ANNALS OF ONCOLOGY (2018)
Will Rogers: actor, humourist ... and ALL epidemiologist?
Robert Hills
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group
Dennis A. Eichenauer et al.
BLOOD (2018)
High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party
Saad Akhtar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
New methods for estimating follow-up rates in cohort studies
Xiaonan Xue et al.
BMC MEDICAL RESEARCH METHODOLOGY (2017)
Ofatumumab in relapsed nodular lymphocyte-predominant Hodgkin lymphoma: results of a phase II study from the German Hodgkin study group
D. A. Eichenauer et al.
LEUKEMIA (2016)
Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution
Saad Sirop Kenderian et al.
BLOOD (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Relapsed or poorly responsive nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents - a report from the United Kingdom's Children's Cancer and Leukaemia Study Group
Ananth G. Shankar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Complete remission following lenalidomide and rituximab in a patient with heavily pretreated nodular lymphocyte predominant Hodgkin lymphoma
Chan Yoon Cheah et al.
LEUKEMIA & LYMPHOMA (2016)
Long-Term Course of Patients With Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the German Hodgkin Study Group
Dennis A. Eichenauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
Carla Casulo et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Ranjana H. Advani et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Meghan Karuturi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)
Sylvia Hartmann et al.
BLOOD (2013)
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
Elias Campo et al.
BLOOD (2011)
Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma
Boris Boell et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Transformation to Aggressive Lymphoma in Nodular Lymphocyte-Predominant Hodgkin's Lymphoma
Mubarak Al-Mansour et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Lymphocyte-predominant and classical Hodgkin's lymphoma:: A comprehensive analysis from the German Hodgkin study group
Lucia Nogova et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)
Holger Schulz et al.
BLOOD (2008)
Lymphorna incidence patterns by WHO subtype in the United States, 1992-2001
LM Morton et al.
BLOOD (2006)
Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation
Z Fan et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2003)
Share Paper
